astaxanthin

Overview

Astaxanthin is a naturally occurring carotenoid pigment with strong antioxidant activity. It is found in microalgae such as Haematococcus pluvialis and is also accumulated in various marine organisms through the food chain. In biomedical research, astaxanthin is of interest because its redox-modulating properties may help counter oxidative stress, inflammation, and cell injury in a range of disease settings.

Although astaxanthin is not a conventional drug target in the receptor sense, it is frequently studied as a bioactive natural compound with potential therapeutic and nutraceutical roles. Recent work has explored its use in cancer-related radiosensitization, neuroprotection, metabolic and renal disease, reproductive cryoprotection, and as a payload in advanced delivery systems designed to improve stability, bioavailability, and tissue targeting. Mechanistically, the studies cited here connect astaxanthin with pathways involving oxidative stress, apoptosis, TLR4 signaling, inflammatory mediators such as interleukin-6, and protective factors including B-cell lymphoma 2, HSP90AA1, TGF-β1, and VEGF.

Focus of Latest Publications

Recent publications have investigated astaxanthin across diverse therapeutic and biotechnological applications, with particular focus on overcoming its limited aqueous solubility and stability through novel delivery formulations. Studies have demonstrated that astaxanthin can be effectively encapsulated into Pickering emulsions stabilized by protein-based nanoparticles—including pea protein isolate-chitosan complexes, proanthocyanidin nanoparticles, and sea bass protein-konjac glucomannan complexes—all of which improved astaxanthin encapsulation efficiency and bioaccessibility. More advanced formulations employing lipid-based nanocarriers, such as liver-targeted garlic exosome-like nanovesicles and liposomal carriers incorporating TPGS (d-α-tocopherol polyethylene glycol 1000 succinate), demonstrated enhanced transepithelial transport and stability during gastrointestinal transit. Spirulina immunoactive peptide-based nanoemulsions also enhanced stability under variable pH, ionic strength, and storage conditions.

Astaxanthin's antioxidant and anti-inflammatory properties have shown therapeutic potential in multiple disease models. In ischemic stroke, astaxanthin pre-treatment reduced neuronal apoptosis and improved neurological deficits by inhibiting the toll-like receptor 4 (TLR4) signaling pathway, decreasing brain edema and infarction volume. In alcoholic liver disease, liver-targeted astaxanthin delivery mitigated oxidative damage, reduced inflammatory cytokine levels, restored mitochondrial function, and alleviated hepatic lipid accumulation through modulation of the TLR4/MyD88/NF-κB pathway. A DHA-acylated astaxanthin ester demonstrated renoprotective effects against diabetic nephropathy in mice superior to equimolar free astaxanthin plus DHA, with protective mechanisms involving selective colonic enrichment, increased trehalose production, and interaction with the molecular target HSP90AA1.

In reproductive applications, astaxanthin has provided significant protective effects during semen cryopreservation. Astaxanthin-loaded chitosan nanoparticles substantially improved post-thaw sperm motility, viability, membrane and acrosomal integrity in buffalo semen, with enhanced antioxidant capacity, reduced apoptotic markers, and a 24.28% increase in pregnancy rates compared to controls. In ram spermatozoa, astaxanthin combined with melatonin exhibited synergistic cryoprotective effects, with proteomic analysis identifying alterations in proteins associated with motility, oxidative stress regulation, and metabolic processes.

Astaxanthin has been investigated for potential radiosensitization in cancer treatment, with evidence suggesting a dual role whereby it exhibits pro-oxidant effects in cancer cells while maintaining antioxidant properties in normal cells—a mechanism potentially useful for enhancing radiotherapy efficacy. However, when tested for lifespan extension in genetically heterogeneous mice, astaxanthin did not significantly increase longevity despite prior evidence of benefit in other models, highlighting the critical importance of dose and timing variables in aging intervention studies.

Complementing these biological investigations, optimized extraction methods for astaxanthin have been developed. Alkaline hydrolysis of fresh Haematococcus pluvialis biomass provided efficient astaxanthin recovery, while a biphasic methanol-olive oil solvent system produced astaxanthin-enriched oil suitable for cosmetic and industrial applications, eliminating pigment losses associated with conventional drying procedures.

Key Publications

• NEWJun Radiosensitizing effect of astaxanthin on radiation-induced cytotoxicity in breast cancer cells. (Journal of the Egyptian National Cancer Institute, 2026, PMID 42252369): "Astaxanthin (AST), a natural carotenoid with antioxidant properties, requires further investigation for its role in cancer therapy."
• Jun Limited Enzymatic Hydrolysis Pea Protein Isolate-Chitosan Nanoparticles as Emulsifier for Pickering Emulsions: Structural Change, Physicochemical Properties, and Encapsulation for Astaxanthin. (Journal of food science, 2026, PMID 42212358): "for encapsulation of astaxanthin in Pickering emulsions."
• May Ameliorative effect of docosahexaenoic acid-acylated astaxanthin ester on diabetic nephropathy: association with the trehalose/HSP90AA1 and colon-kidney axis. (Food & function, 2026, PMID 42149022): "Specifically, relative to the DHA + AST group, DHA-AST gavage achieved selective colonic DHA enrichment, more effectively ameliorated systemic glucose dyshomeostasis, renal dysfunction, and histopathological damage, and suppressed renal inflammation, oxidative stress and fibrosis."
• May Extraction of astaxanthin from fresh Haematococcus pluvialis biomass: a sustainable approach using vegetable oils. (Archives of microbiology, 2026, PMID 42126613): "we developed an optimized process targeting the key challenges in extracting astaxanthin from fresh H. pluvialis biomass."
• Jun Proteomic Profiling Reveals the Synergistic Effects of Astaxanthin and Melatonin on the Inhibition of Cryoinjuries in Ram Sperm. (Journal of proteome research, 2026, PMID 42101457): "The present study aimed to investigate the protective effects of astaxanthin (AST) and melatonin (MLT) on ram sperm quality-associated indicators during cryopreservation, and to explore the molecular effects of the two cryoprotectants on the protein profile of cryopreserved sperm."
• Apr Transcriptomics and Experiments Verified that Astaxanthin Reduces the Apoptosis of Nerve Cells in Ischemic Stroke by Inhibiting the Toll-like Receptor Signaling Pathway. (Molecular neurobiology, 2026, PMID 42050264): "Astaxanthin (ATX) is a natural product with neuroprotection effects."
• Apr Utilizing spirulina immunoactive peptide-based nanoemulsions to enhance the stability, bioaccessibility and synergistic immune activity of astaxanthin. (Food chemistry, 2026, PMID 41980364): "Astaxanthin (AST) faces challenges in application due to its poor water solubility and low stability."
• Jun Orally engineered liver-targeted garlic exosome-like nanovesicles for astaxanthin precise delivery against alcoholic liver disease in mice. (Food research international (Ottawa, Ont.), 2026, PMID 41956676): "Herein, novel lactobionic acid-modified garlic exosome-like nanovesicles (LA-GELN) were designed to precise delivery astaxanthin (AXT) against alcohol-induced lipid metabolism disorders."
• Apr Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan in UM-HET3 mice. (GeroScience, 2026, PMID 41843349): "Notably, astaxanthin, mitoglitazone, and meclizine-previously associated with lifespan extension in the ITP-showed no benefit when administered at different doses or starting at later ages."
• May Size-controlled and antioxidant proanthocyanidin nanoparticle-stabilized high internal phase Pickering emulsions for astaxanthin delivery. (Food chemistry, 2026, PMID 41818993): "High internal phase Pickering emulsions (HIPPEs) provide a promising platform for astaxanthin (AXT) delivery."